University of Virginia Health System; Hematology/Oncology Division — Charlottesville, Virginia

University of Virginia Health System; Hematology/Oncology Division is a clinical research site located in Charlottesville, Virginia, United States 22908.

Crixeo Clinical Trials Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Virginia Health System; Hematology/Oncology Division has participated in 2 clinical trials.

Therapeutic areas: Myelodysplastic Syndromes, Breast Cancer.

Sponsors: Hoffmann-La Roche.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Charlottesville

Browse all research sites in Virginia · View every site in Charlottesville

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Virginia Health System; Hematology/Oncology Division?

University of Virginia Health System; Hematology/Oncology Division has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Virginia Health System; Hematology/Oncology Division conducted?

University of Virginia Health System; Hematology/Oncology Division has 2 clinical trials on record. Their work covers Myelodysplastic Syndromes, Breast Cancer.

Is University of Virginia Health System; Hematology/Oncology Division accredited by Crixeo Clinical Trials?

University of Virginia Health System; Hematology/Oncology Division has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Virginia Health System; Hematology/Oncology Division?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.